Literature DB >> 18978479

Tolerability of fosamprenavir/ritonavir associated with zidovudine-lamivudine used as postexposure prophylaxis for HIV infection.

Christine Burty, Simona Pavel, Kamel Ghomari, Annie Vermersch, Bernard Christian, Jean Pouaha, Yazdan Yazdanpanah, Thierry May, Christian Rabaud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18978479     DOI： 10.1097/QAI.0b013e31817c1f2d

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  3 in total

Review 1.  Practical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial review.

Authors:  Sachin Jain; Kenneth H Mayer
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

2.  Longitudinal trends in HIV nonoccupational postexposure prophylaxis use at a Boston community health center between 1997 and 2013.

Authors:  Sachin Jain; Catherine E Oldenburg; Matthew J Mimiaga; Kenneth H Mayer
Journal:  J Acquir Immune Defic Syndr       Date:  2015-01-01       Impact factor: 3.731

3.  Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.

Authors:  Nadia Valin; Laurent Fonquernie; Anne Daguenel; Pauline Campa; Theresita Anthony; Marguerite Guiguet; Pierre Marie Girard; Marie Caroline Meyohas
Journal:  BMC Infect Dis       Date:  2016-11-29       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.